indazoles has been researched along with Rhabdoid Tumor in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, AW; de Andrade, A; Gokirmak, T; Gross, JN; Kondo, A; Piper, DR; Sredni, ST; Suzuki, M; Tomita, T; Topczewski, J; Yang, JP | 1 |
| Andrianteranagna, M; Anthony, E; Aynaud, MM; Baulande, S; Bohec, M; Bourdeaut, F; Cairo, S; Chauvin, C; Del Nery, E; Delattre, O; Han, ZY; Leruste, A; Lescure, A; Maillot, L; Masliah-Planchon, J; Richer, W; Roman-Roman, S; Surdez, D; Tauziede-Espariat, A; Zaidi, S | 1 |
| Broncel, M; Crosier, S; Daley, F; Finetti, MA; Holmes, K; Huang, PH; Jenks, A; Luczynski, MT; McCarthy, F; Natrajan, RC; Payne, LS; Ryall, KA; Tan, AC; Tanos, B; Todd, JR; Vyse, S; Wai, P; Williamson, D; Wong, JP | 1 |
3 other study(ies) available for indazoles and Rhabdoid Tumor
| Article | Year |
|---|---|
A functional screening of the kinome identifies the Polo-like kinase 4 as a potential therapeutic target for malignant rhabdoid tumors, and possibly, other embryonal tumors of the brain.
Topics: Amino Acid Sequence; Animals; Brain Neoplasms; Cell Cycle; Cell Proliferation; CRISPR-Cas Systems; High-Throughput Screening Assays; Humans; Indazoles; Indoles; Larva; Mutation; Protein Serine-Threonine Kinases; Rhabdoid Tumor; Sequence Alignment; Tumor Cells, Cultured; Zebrafish | 2017 |
High-Throughput Drug Screening Identifies Pazopanib and Clofilium Tosylate as Promising Treatments for Malignant Rhabdoid Tumors.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Discovery; Endoplasmic Reticulum Stress; High-Throughput Screening Assays; Humans; Indazoles; Protein Kinase Inhibitors; Pyrimidines; Quaternary Ammonium Compounds; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Rhabdoid Tumor; SMARCB1 Protein; Sulfonamides | 2017 |
Dual Targeting of PDGFRα and FGFR1 Displays Synergistic Efficacy in Malignant Rhabdoid Tumors.
Topics: Apoptosis; Cell Line, Tumor; Dasatinib; Drug Resistance, Neoplasm; Gene Expression Profiling; Humans; Indazoles; Indoles; Oncogenes; Pyrimidines; Pyrroles; Receptor, Fibroblast Growth Factor, Type 1; Receptor, Platelet-Derived Growth Factor alpha; Rhabdoid Tumor; Sulfonamides; Sunitinib | 2016 |